Tassilo A. Wachsmann

Leiden, ZH 2333ZA, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.

Journal: Blood

Published: December 09, 2025

Durable epigenetic silencing with a TALE-based editor.

Durable epigenetic silencing with a TALE-based editor.

Journal: Nature biotechnology

Published: October 08, 2025

CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome.

CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome.

Journal: Trends in cancer

Published: May 06, 2025

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

DNA-demethylation by DAC induces MAGE expression and MAGE-specific T cell reactivity against tumors but also healthy cell subsets.

Journal: Molecular therapy. Oncology

Published: August 28, 2024

Targeting epigenetic regulation and post-translational modification with 5-Aza-2' deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy.

Targeting epigenetic regulation and post-translational modification with 5-Aza-2' deoxycytidine and SUMO E1 inhibition augments T-cell receptor therapy.

Journal: Journal for immunotherapy of cancer

Published: June 07, 2024

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

CAR-mediated target recognition limits TCR-mediated target recognition of TCR- and CAR-dual-receptor-edited T cells.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 08, 2024

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy.

Journal: Molecular therapy oncolytics

Published: November 03, 2023

CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer.

CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer.

Journal: Molecular therapy. Nucleic acids

Published: September 14, 2023

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Combining BCMA-targeting CAR T cells with TCR-engineered T-cell therapy to prevent immune escape of multiple myeloma.

Journal: Blood advances

Published: April 07, 2023

High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs.

High-affinity CD8 variants enhance the sensitivity of pMHCI antigen recognition via low-affinity TCRs.

Journal: The Journal of biological chemistry

Published: February 15, 2023

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer.

Journal: Frontiers in immunology

Published: December 12, 2022

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain.

Journal: Journal of hematology & oncology

Published: November 17, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026